Source: Alimentary Pharmacology and Therapeutics. Unidade: FM
Subjects: ESTUDOS RANDOMIZADOS, SATISFAÇÃO DO PACIENTE, FÁRMACOS (SISTEMA DIGESTÓRIO) (APLICAÇÕES TERAPÊUTICAS), REFLUXO GASTROESOFÁGICO (TERAPIA)
ABNT
MORAES-FILHO, J. P. e PEDROSO, M. e QUIGLEY, E. M. M. Randomised clinical trial: Daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms. Alimentary Pharmacology and Therapeutics, v. 39, n. 1, p. 47-56, 2014Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/apt.12540/pdf. Acesso em: 20 out. 2024.APA
Moraes-Filho, J. P., Pedroso, M., & Quigley, E. M. M. (2014). Randomised clinical trial: Daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms. Alimentary Pharmacology and Therapeutics, 39( 1), 47-56. doi:10.1111/apt.12540NLM
Moraes-Filho JP, Pedroso M, Quigley EMM. Randomised clinical trial: Daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms [Internet]. Alimentary Pharmacology and Therapeutics. 2014 ; 39( 1): 47-56.[citado 2024 out. 20 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/apt.12540/pdfVancouver
Moraes-Filho JP, Pedroso M, Quigley EMM. Randomised clinical trial: Daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms [Internet]. Alimentary Pharmacology and Therapeutics. 2014 ; 39( 1): 47-56.[citado 2024 out. 20 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/apt.12540/pdf